| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2F2 DRD5 MAS1L HTR4 OR1B1 OR5B2 MLNR MAS1 FPR3 OR6C74 ABCC9 GRIN2A GRIN2B GRIN2C GRIN2D OR2F1 PTGER4 TAS2R10 PTPRC CELSR3 ACKR3 MRGPRX1 GPR75 AGTR1 PKD1 MRGPRX3 TACR1 TAS2R40 ADGRA3 HRH3 GABRA6 | 4.03e-10 | 1353 | 129 | 31 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2F2 DRD5 MAS1L HTR4 OR1B1 OR5B2 MLNR MAS1 FPR3 OR6C74 OR2F1 PTGER4 TAS2R10 CELSR3 ACKR3 MRGPRX1 GPR75 AGTR1 MRGPRX3 TACR1 TAS2R40 ADGRA3 HRH3 | 1.06e-08 | 884 | 129 | 23 | GO:0004930 |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.14e-07 | 8 | 129 | 4 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 1.14e-07 | 8 | 129 | 4 | GO:0004972 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.76e-07 | 100 | 129 | 8 | GO:0030594 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 5.49e-07 | 75 | 129 | 7 | GO:0098960 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.55e-06 | 31 | 129 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.43e-06 | 133 | 129 | 8 | GO:0008528 | |
| GeneOntologyMolecularFunction | angiotensin receptor activity | 2.61e-06 | 5 | 129 | 3 | GO:0001595 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 3.57e-06 | 140 | 129 | 8 | GO:0001653 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 3.71e-06 | 17 | 129 | 4 | GO:0004970 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 2.25e-05 | 180 | 129 | 8 | GO:0004866 | |
| GeneOntologyMolecularFunction | transporter activity | ATP8B4 ABCA13 MFSD2B ABCC9 GRIN2A GRIN2B GRIN2C GRIN2D ATP13A2 ABCA10 SLC52A3 CLPTM1L SLC12A1 SLCO1C1 TMEM184A PKD1 PKD2 SLC4A4 SLC38A6 KCNH5 SLC23A3 GABRA6 | 2.54e-05 | 1289 | 129 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.60e-05 | 27 | 129 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 2.96e-05 | 187 | 129 | 8 | GO:0030414 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.33e-05 | 57 | 129 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.28e-05 | 60 | 129 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 4.94e-05 | 201 | 129 | 8 | GO:0061135 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 6.30e-05 | 65 | 129 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 6.30e-05 | 65 | 129 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | glutamate binding | 9.10e-05 | 14 | 129 | 3 | GO:0016595 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.42e-04 | 77 | 129 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | GBP6 ATP8B4 GBP7 ABCA13 LRRK2 GBP1 GBP2 ABCC9 YTHDC2 ATP13A2 ABCA10 GBP4 GBP5 KIF28P AQR | 1.46e-04 | 775 | 129 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.83e-04 | 182 | 129 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.92e-04 | 129 | 129 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.95e-04 | 184 | 129 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA13 MFSD2B ABCC9 GRIN2A GRIN2B GRIN2C GRIN2D ATP13A2 ABCA10 SLC52A3 SLC12A1 SLCO1C1 PKD1 PKD2 SLC4A4 SLC38A6 KCNH5 SLC23A3 GABRA6 | 2.06e-04 | 1180 | 129 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | angiotensin type II receptor activity | 2.46e-04 | 4 | 129 | 2 | GO:0004945 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.62e-04 | 193 | 129 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 2.69e-04 | 257 | 129 | 8 | GO:0061134 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.81e-04 | 49 | 129 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.96e-04 | 197 | 129 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.99e-04 | 140 | 129 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | GBP6 ATP8B4 GBP7 ABCA13 LRRK2 GBP1 GBP2 ABCC9 YTHDC2 ATP13A2 ABCA10 GBP4 GBP5 KIF28P AQR | 3.43e-04 | 839 | 129 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | GBP6 ATP8B4 GBP7 ABCA13 LRRK2 GBP1 GBP2 ABCC9 YTHDC2 ATP13A2 ABCA10 GBP4 GBP5 KIF28P AQR | 3.47e-04 | 840 | 129 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | GBP6 ATP8B4 GBP7 ABCA13 LRRK2 GBP1 GBP2 ABCC9 YTHDC2 ATP13A2 ABCA10 GBP4 GBP5 KIF28P AQR | 3.47e-04 | 840 | 129 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.49e-04 | 151 | 129 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 4.83e-04 | 24 | 129 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | molecular function inhibitor activity | SERPINA3 GBP6 LRRK2 GBP1 GBP2 SERPINA12 HMSD GBP5 PKD1 PKD2 ITIH6 SERPINA9 | 4.90e-04 | 596 | 129 | 12 | GO:0140678 |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | SERPINA3 GBP6 LRRK2 GBP1 GBP2 SERPINA12 HMSD GBP5 ITIH6 SERPINA9 | 5.32e-04 | 435 | 129 | 10 | GO:0004857 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 6.00e-04 | 105 | 129 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 6.00e-04 | 105 | 129 | 5 | GO:0004867 | |
| GeneOntologyMolecularFunction | 3'-5' RNA helicase activity | 6.11e-04 | 6 | 129 | 2 | GO:0034458 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 6.43e-04 | 293 | 129 | 8 | GO:0008514 | |
| GeneOntologyMolecularFunction | clathrin binding | 7.37e-04 | 63 | 129 | 4 | GO:0030276 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 8.51e-04 | 7 | 129 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ABCC9 GRIN2A GRIN2B GRIN2C GRIN2D SLC12A1 PKD1 PKD2 SLC4A4 KCNH5 | 8.88e-04 | 465 | 129 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | methyl-CpG binding | 1.04e-03 | 31 | 129 | 3 | GO:0008327 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.36e-03 | 34 | 129 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.49e-03 | 334 | 129 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.74e-03 | 196 | 129 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.76e-03 | 343 | 129 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.28e-03 | 207 | 129 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.34e-03 | 208 | 129 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 2.62e-03 | 12 | 129 | 2 | GO:0004382 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 2.62e-03 | 12 | 129 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.99e-03 | 459 | 129 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 3.09e-03 | 152 | 129 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ABCC9 GRIN2A GRIN2B GRIN2C GRIN2D ATP13A2 SLC12A1 PKD1 PKD2 SLC4A4 KCNH5 | 3.88e-03 | 664 | 129 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | amyloid-beta binding | 4.34e-03 | 102 | 129 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | peptide binding | 4.65e-03 | 318 | 129 | 7 | GO:0042277 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.68e-03 | 16 | 129 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 4.88e-03 | 53 | 129 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 5.22e-03 | 172 | 129 | 5 | GO:0044325 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol binding | 5.29e-03 | 17 | 129 | 2 | GO:0005545 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ABCC9 GRIN2A GRIN2B GRIN2C GRIN2D ATP13A2 SLC12A1 PKD1 PKD2 SLC4A4 KCNH5 GABRA6 | 5.31e-03 | 793 | 129 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.49e-03 | 109 | 129 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | G protein activity | 6.58e-03 | 59 | 129 | 3 | GO:0003925 | |
| GeneOntologyMolecularFunction | GTPase activity | 6.75e-03 | 341 | 129 | 7 | GO:0003924 | |
| GeneOntologyMolecularFunction | channel activity | 7.10e-03 | 525 | 129 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.19e-03 | 526 | 129 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 7.29e-03 | 20 | 129 | 2 | GO:0017110 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ABCC9 GRIN2A GRIN2B GRIN2C GRIN2D SLC12A1 PKD1 PKD2 SLC4A4 KCNH5 | 7.55e-03 | 627 | 129 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.95e-03 | 441 | 129 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 8.03e-03 | 21 | 129 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 8.79e-03 | 22 | 129 | 2 | GO:0004993 | |
| GeneOntologyBiologicalProcess | cytolysis | 4.55e-11 | 12 | 128 | 6 | GO:0019835 | |
| GeneOntologyBiologicalProcess | cytolysis in another organism | 1.05e-09 | 9 | 128 | 5 | GO:0051715 | |
| GeneOntologyBiologicalProcess | positive regulation of pyroptotic inflammatory response | 1.05e-09 | 9 | 128 | 5 | GO:0140639 | |
| GeneOntologyBiologicalProcess | adhesion of symbiont to host | 1.22e-07 | 20 | 128 | 5 | GO:0044406 | |
| GeneOntologyBiologicalProcess | startle response | 1.91e-07 | 41 | 128 | 6 | GO:0001964 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2F2 DRD5 MAS1L HTR4 OR1B1 OR5B2 MLNR MAS1 FPR3 OR6C74 LRRK2 MFSD2B OR2F1 PTGER4 ADCY3 TAS2R10 CELSR3 ACKR3 MRGPRX1 GPR75 AGTR1 MRGPRX3 TACR1 TAS2R40 ADGRA3 HRH3 | 3.69e-07 | 1395 | 128 | 26 | GO:0007186 |
| GeneOntologyBiologicalProcess | positive regulation of AIM2 inflammasome complex assembly | 9.30e-07 | 4 | 128 | 3 | GO:0140973 | |
| GeneOntologyBiologicalProcess | regulation of terminal button organization | 9.30e-07 | 4 | 128 | 3 | GO:2000331 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle endocytosis | 9.69e-07 | 13 | 128 | 4 | GO:1900244 | |
| GeneOntologyBiologicalProcess | excitatory chemical synaptic transmission | 2.43e-06 | 16 | 128 | 4 | GO:0098976 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 3.11e-06 | 65 | 128 | 6 | GO:0098815 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle recycling | 3.16e-06 | 17 | 128 | 4 | GO:1903423 | |
| GeneOntologyBiologicalProcess | defense response to protozoan | 4.14e-06 | 39 | 128 | 5 | GO:0042832 | |
| GeneOntologyBiologicalProcess | regulation of AIM2 inflammasome complex assembly | 4.61e-06 | 6 | 128 | 3 | GO:0140971 | |
| GeneOntologyBiologicalProcess | cellular response to interferon-beta | 5.33e-06 | 41 | 128 | 5 | GO:0035458 | |
| GeneOntologyBiologicalProcess | response to protozoan | 6.02e-06 | 42 | 128 | 5 | GO:0001562 | |
| GeneOntologyBiologicalProcess | pyroptotic inflammatory response | 6.02e-06 | 42 | 128 | 5 | GO:0070269 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | LRRK2 GBP1 GRIN2A GRIN2B GRIN2C GRIN2D PTPRC ACKR3 AGTR1 PKD2 | 6.41e-06 | 266 | 128 | 10 | GO:0019722 |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 6.78e-06 | 43 | 128 | 5 | GO:2000463 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 6.78e-06 | 43 | 128 | 5 | GO:0051968 | |
| GeneOntologyBiologicalProcess | response to interferon-beta | 1.18e-05 | 48 | 128 | 5 | GO:0035456 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 1.28e-05 | 8 | 128 | 3 | GO:2000809 | |
| GeneOntologyBiologicalProcess | AIM2 inflammasome complex assembly | 1.28e-05 | 8 | 128 | 3 | GO:0140970 | |
| GeneOntologyBiologicalProcess | associative learning | 1.69e-05 | 130 | 128 | 7 | GO:0008306 | |
| GeneOntologyBiologicalProcess | terminal button organization | 1.91e-05 | 9 | 128 | 3 | GO:0072553 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 2.22e-05 | 27 | 128 | 4 | GO:0035235 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 2.34e-05 | 92 | 128 | 6 | GO:0051966 | |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 2.71e-05 | 10 | 128 | 3 | GO:0097151 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response | 2.79e-05 | 193 | 128 | 8 | GO:0050729 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 3.26e-05 | 59 | 128 | 5 | GO:0007215 | |
| GeneOntologyBiologicalProcess | behavior | RAG1 DRD5 RASGRF1 LRRK2 GRIN2A GRIN2B GRIN2D PTGER4 PICALM ADCY3 NLGN3 MRGPRX1 AGTR1 MRGPRX3 TACR1 SLITRK6 HRH3 | 3.71e-05 | 891 | 128 | 17 | GO:0007610 |
| GeneOntologyBiologicalProcess | modulation of inhibitory postsynaptic potential | 4.93e-05 | 12 | 128 | 3 | GO:0098828 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 4.93e-05 | 12 | 128 | 3 | GO:2000807 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle endocytosis | 5.04e-05 | 33 | 128 | 4 | GO:1900242 | |
| GeneOntologyBiologicalProcess | learning | 5.43e-05 | 212 | 128 | 8 | GO:0007612 | |
| GeneOntologyBiologicalProcess | cellular response to type II interferon | 7.83e-05 | 114 | 128 | 6 | GO:0071346 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 7.99e-05 | 224 | 128 | 8 | GO:0007204 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.04e-04 | 75 | 128 | 5 | GO:0050982 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 1.09e-04 | 40 | 128 | 4 | GO:1990806 | |
| GeneOntologyBiologicalProcess | learning or memory | RAG1 DRD5 RASGRF1 GRIN2A GRIN2B PICALM ADCY3 NLGN3 TACR1 HRH3 | 1.13e-04 | 373 | 128 | 10 | GO:0007611 |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 1.23e-04 | 16 | 128 | 3 | GO:0051290 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.33e-04 | 180 | 128 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | killing of cells of another organism | 1.55e-04 | 129 | 128 | 6 | GO:0031640 | |
| GeneOntologyBiologicalProcess | disruption of cell in another organism | 1.55e-04 | 129 | 128 | 6 | GO:0141061 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 1.57e-04 | 247 | 128 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle recycling | 1.58e-04 | 44 | 128 | 4 | GO:1903421 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2F2 OR1B1 OR5B2 OR6C74 GRIN2A GRIN2B GRIN2D OR2F1 TAS2R10 LPO PKD1 PKD2 TACR1 TAS2R40 | 1.60e-04 | 722 | 128 | 14 | GO:0051606 |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 1.62e-04 | 130 | 128 | 6 | GO:0060079 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 1.68e-04 | 83 | 128 | 5 | GO:0048168 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.76e-04 | 132 | 128 | 6 | GO:0035249 | |
| GeneOntologyBiologicalProcess | disruption of anatomical structure in another organism | 1.76e-04 | 132 | 128 | 6 | GO:0141060 | |
| GeneOntologyBiologicalProcess | drinking behavior | 1.78e-04 | 18 | 128 | 3 | GO:0042756 | |
| GeneOntologyBiologicalProcess | regulation of presynapse organization | 1.89e-04 | 46 | 128 | 4 | GO:0099174 | |
| GeneOntologyBiologicalProcess | directional locomotion | 2.27e-04 | 4 | 128 | 2 | GO:0033058 | |
| GeneOntologyBiologicalProcess | response to type II interferon | 2.51e-04 | 141 | 128 | 6 | GO:0034341 | |
| GeneOntologyBiologicalProcess | cognition | RAG1 DRD5 RASGRF1 GRIN2A GRIN2B PICALM ADCY3 NLGN3 TACR1 HRH3 | 3.12e-04 | 423 | 128 | 10 | GO:0050890 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 3.14e-04 | 147 | 128 | 6 | GO:0099565 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 3.30e-04 | 22 | 128 | 3 | GO:0097091 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 3.31e-04 | 96 | 128 | 5 | GO:0048488 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 3.50e-04 | 150 | 128 | 6 | GO:0050830 | |
| GeneOntologyBiologicalProcess | response to chloroquine | 3.77e-04 | 5 | 128 | 2 | GO:1902349 | |
| GeneOntologyBiologicalProcess | sensitization | 3.77e-04 | 5 | 128 | 2 | GO:0046960 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 4.17e-04 | 217 | 128 | 7 | GO:0097553 | |
| GeneOntologyBiologicalProcess | maintenance of gastrointestinal epithelium | 4.30e-04 | 24 | 128 | 3 | GO:0030277 | |
| GeneOntologyBiologicalProcess | angiotensin-activated signaling pathway | 4.30e-04 | 24 | 128 | 3 | GO:0038166 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 4.38e-04 | 102 | 128 | 5 | GO:0140238 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammasome-mediated signaling pathway | 5.47e-04 | 26 | 128 | 3 | GO:0141087 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of pain | 5.47e-04 | 26 | 128 | 3 | GO:0050966 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | GBP6 DRD5 MAS1L GBP7 MAS1 LRRK2 GBP1 GBP2 ABCC9 GRIN2A GRIN2D PTGER4 ADCY3 SERPINA12 PHEX GBP4 GBP5 AGTR1 PKD2 HRH3 | 6.09e-04 | 1450 | 128 | 20 | GO:1901701 |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 6.12e-04 | 27 | 128 | 3 | GO:0060080 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 6.37e-04 | 233 | 128 | 7 | GO:0050806 | |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 6.45e-04 | 111 | 128 | 5 | GO:0036465 | |
| GeneOntologyBiologicalProcess | cell killing | 6.71e-04 | 307 | 128 | 8 | GO:0001906 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | LRRK2 ABCC9 GRIN2A GRIN2B GRIN2C GRIN2D NLGN3 TACR1 SLC4A4 KCNH5 GABRA6 | 7.33e-04 | 559 | 128 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | inflammatory response | SERPINA3 GBP7 MAS1 FPR3 LRRK2 GBP1 GBP2 PTGER4 OLR1 PTPRC GBP4 GBP5 MRGPRX1 AGTR1 MRGPRX3 TACR1 | 7.41e-04 | 1043 | 128 | 16 | GO:0006954 |
| GeneOntologyBiologicalProcess | response to alcohol | 7.46e-04 | 312 | 128 | 8 | GO:0097305 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle transport | 7.86e-04 | 7 | 128 | 2 | GO:1902803 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 7.90e-04 | 175 | 128 | 6 | GO:0031644 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 7.90e-04 | 175 | 128 | 6 | GO:0009582 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | TMEM67 SERPINA3 DRD5 MAS1L MAS1 LRRK2 ABCC9 GRIN2A GRIN2B GRIN2D SERPINA12 PHEX CCNG1 MRGPRX1 AGTR1 PKD2 MRGPRX3 HRH3 | 8.73e-04 | 1272 | 128 | 18 | GO:1901698 |
| GeneOntologyBiologicalProcess | chemosensory behavior | 9.24e-04 | 31 | 128 | 3 | GO:0007635 | |
| GeneOntologyBiologicalProcess | protein heterooligomerization | 9.24e-04 | 31 | 128 | 3 | GO:0051291 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to plasma membrane | 9.24e-04 | 31 | 128 | 3 | GO:1903077 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 9.69e-04 | 405 | 128 | 9 | GO:0042742 | |
| GeneOntologyBiologicalProcess | synaptic vesicle localization | 9.97e-04 | 71 | 128 | 4 | GO:0097479 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2F2 OR1B1 OR5B2 OR6C74 GRIN2A GRIN2B GRIN2D OR2F1 TAS2R10 LPO TAS2R40 | 1.02e-03 | 582 | 128 | 11 | GO:0050906 |
| GeneOntologyBiologicalProcess | presynapse organization | 1.11e-03 | 73 | 128 | 4 | GO:0099172 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to cell periphery | 1.11e-03 | 33 | 128 | 3 | GO:1904376 | |
| GeneOntologyBiologicalProcess | brain renin-angiotensin system | 1.34e-03 | 9 | 128 | 2 | GO:0002035 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response | 1.41e-03 | 515 | 128 | 10 | GO:0050727 | |
| GeneOntologyBiologicalProcess | visual learning | 1.42e-03 | 78 | 128 | 4 | GO:0008542 | |
| GeneOntologyBiologicalProcess | epithelial structure maintenance | 1.44e-03 | 36 | 128 | 3 | GO:0010669 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 1.49e-03 | 198 | 128 | 6 | GO:0007259 | |
| GeneOntologyCellularComponent | host cell part | 4.94e-11 | 6 | 129 | 5 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 4.94e-11 | 6 | 129 | 5 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 4.94e-11 | 6 | 129 | 5 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 4.94e-11 | 6 | 129 | 5 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 4.94e-11 | 6 | 129 | 5 | GO:0020005 | |
| GeneOntologyCellularComponent | host intracellular region | 4.94e-11 | 6 | 129 | 5 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 4.94e-11 | 6 | 129 | 5 | GO:0030430 | |
| GeneOntologyCellularComponent | host cellular component | 2.37e-08 | 15 | 129 | 5 | GO:0018995 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 1.70e-07 | 9 | 129 | 4 | GO:0017146 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.26e-05 | 8 | 129 | 3 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 1.88e-05 | 9 | 129 | 3 | GO:0044217 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.59e-05 | 201 | 129 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | polycystin complex | 3.78e-05 | 2 | 129 | 2 | GO:0002133 | |
| GeneOntologyCellularComponent | cell surface | STAB2 MAS1 LYZL6 GRIN2A GRIN2B LCT PICALM NLGN3 ICOS PTPRC SLC12A1 ACKR3 MRGPRX1 PKD1 TACR1 SLITRK6 SLC4A4 ADGRA3 KCNH5 | 5.16e-05 | 1111 | 129 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.42e-04 | 43 | 129 | 4 | GO:0098688 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | TMEM67 ATP8B4 STAB2 CLTCL1 GBP7 ABCA13 LRRK2 GBP1 GBP2 GRIN2A GRIN2B ATP13A2 OLR1 PTPRC TMEM184A GBP5 SNAP91 PKD1 PKD2 ELAPOR1 | 1.48e-04 | 1307 | 129 | 20 | GO:0030659 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.70e-04 | 45 | 129 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | vesicle membrane | TMEM67 ATP8B4 STAB2 CLTCL1 GBP7 ABCA13 LRRK2 GBP1 GBP2 GRIN2A GRIN2B ATP13A2 OLR1 PTPRC TMEM184A GBP5 SNAP91 PKD1 PKD2 ELAPOR1 | 1.77e-04 | 1325 | 129 | 20 | GO:0012506 |
| GeneOntologyCellularComponent | postsynaptic membrane | DRD5 GRIN2A GRIN2B GRIN2C GRIN2D PICALM NLGN3 CELSR3 SNAP91 GABRA6 | 2.12e-04 | 405 | 129 | 10 | GO:0045211 |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.56e-04 | 50 | 129 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | ciliary membrane | 3.55e-04 | 98 | 129 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 4.34e-04 | 157 | 129 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | excitatory synapse | 5.32e-04 | 107 | 129 | 5 | GO:0060076 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DRD5 HTR4 RASGRF1 LRRK2 GRIN2A GRIN2B PTGER4 ATP13A2 PICALM CCNG1 NLGN3 SNAP91 MRGPRX1 AGTR1 MRGPRX3 TACR1 HRH3 GABRA6 | 5.46e-04 | 1228 | 129 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 5.73e-04 | 378 | 129 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | extrinsic component of presynaptic endocytic zone membrane | 7.78e-04 | 7 | 129 | 2 | GO:0098894 | |
| GeneOntologyCellularComponent | postsynaptic specialization | DRD5 GRIN2A GRIN2B GRIN2C GRIN2D PICALM NLGN3 CELSR3 SNAP91 GABRA6 | 1.14e-03 | 503 | 129 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | migrasome | 1.32e-03 | 9 | 129 | 2 | GO:0140494 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.39e-03 | 78 | 129 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | DRD5 GRIN2A GRIN2B GRIN2C GRIN2D PICALM NLGN3 CELSR3 SNAP91 GABRA6 | 1.52e-03 | 523 | 129 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.52e-03 | 80 | 129 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.68e-03 | 277 | 129 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | cell body | DRD5 RASGRF1 LRRK2 GRIN2B PTGER4 ATP13A2 PICALM CCNG1 NLGN3 SNAP91 MRGPRX1 MRGPRX3 TACR1 GABRA6 | 1.80e-03 | 929 | 129 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | DRD5 RASGRF1 LRRK2 GRIN2B PTGER4 ATP13A2 PICALM CCNG1 NLGN3 SNAP91 MRGPRX1 MRGPRX3 GABRA6 | 1.98e-03 | 835 | 129 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | transporter complex | ATP8B4 ABCC9 GRIN2A GRIN2B GRIN2C GRIN2D PKD1 PKD2 KCNH5 GABRA6 | 2.20e-03 | 550 | 129 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | neuronal cell body membrane | 2.37e-03 | 43 | 129 | 3 | GO:0032809 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.85e-03 | 477 | 129 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | cell body membrane | 3.05e-03 | 47 | 129 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | presynaptic endocytic zone membrane | 3.28e-03 | 14 | 129 | 2 | GO:0098835 | |
| GeneOntologyCellularComponent | synaptic membrane | DRD5 GRIN2A GRIN2B GRIN2C GRIN2D PICALM NLGN3 CELSR3 SNAP91 GABRA6 | 3.34e-03 | 583 | 129 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.76e-03 | 320 | 129 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | clathrin coat | 5.01e-03 | 56 | 129 | 3 | GO:0030118 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 5.19e-03 | 523 | 129 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | cell projection membrane | 5.34e-03 | 431 | 129 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | presynaptic endocytic zone | 5.42e-03 | 18 | 129 | 2 | GO:0098833 | |
| GeneOntologyCellularComponent | extrinsic component of presynaptic membrane | 5.42e-03 | 18 | 129 | 2 | GO:0098888 | |
| GeneOntologyCellularComponent | basal plasma membrane | 6.47e-03 | 354 | 129 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | dendrite | DRD5 HTR4 RASGRF1 LRRK2 GRIN2A GRIN2B CCNG1 NLGN3 AGTR1 TACR1 HRH3 GABRA6 | 6.86e-03 | 858 | 129 | 12 | GO:0030425 |
| GeneOntologyCellularComponent | postsynaptic density | 6.96e-03 | 451 | 129 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | dendritic tree | DRD5 HTR4 RASGRF1 LRRK2 GRIN2A GRIN2B CCNG1 NLGN3 AGTR1 TACR1 HRH3 GABRA6 | 6.98e-03 | 860 | 129 | 12 | GO:0097447 |
| GeneOntologyCellularComponent | sperm midpiece | 7.27e-03 | 64 | 129 | 3 | GO:0097225 | |
| GeneOntologyCellularComponent | clathrin coat of coated pit | 7.35e-03 | 21 | 129 | 2 | GO:0030132 | |
| MousePheno | abnormal kidney physiology | SERPINA3 DRD5 MAS1 LRRK2 ADCY3 PHEX PTPRC SLC12A1 LPO AGTR1 PKD1 PKD2 SLC4A4 | 2.99e-06 | 372 | 102 | 13 | MP:0002136 |
| MousePheno | decreased circulating renin level | 4.36e-05 | 10 | 102 | 3 | MP:0003353 | |
| MousePheno | abnormal circulating renin level | 5.52e-05 | 29 | 102 | 4 | MP:0003349 | |
| Domain | GBP_C | 1.56e-11 | 10 | 124 | 6 | PF02841 | |
| Domain | G_GB1_RHD3_dom | 3.41e-11 | 11 | 124 | 6 | IPR030386 | |
| Domain | Guanylate-bd_N | 3.41e-11 | 11 | 124 | 6 | IPR015894 | |
| Domain | Guanylate-bd_C | 3.41e-11 | 11 | 124 | 6 | IPR003191 | |
| Domain | GBP | 3.41e-11 | 11 | 124 | 6 | PF02263 | |
| Domain | G_GB1_RHD3 | 3.41e-11 | 11 | 124 | 6 | PS51715 | |
| Domain | GPCR_Rhodpsn_7TM | OR2F2 DRD5 MAS1L HTR4 OR1B1 OR5B2 MLNR MAS1 FPR3 OR6C74 OR2F1 PTGER4 ACKR3 MRGPRX1 GPR75 AGTR1 MRGPRX3 TACR1 HRH3 | 9.08e-08 | 670 | 124 | 19 | IPR017452 |
| Domain | 7tm_1 | OR2F2 DRD5 MAS1L HTR4 OR1B1 OR5B2 MLNR MAS1 FPR3 OR6C74 OR2F1 PTGER4 ACKR3 MRGPRX1 GPR75 AGTR1 MRGPRX3 TACR1 HRH3 | 1.07e-07 | 677 | 124 | 19 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2F2 DRD5 MAS1L HTR4 OR1B1 OR5B2 MLNR MAS1 FPR3 OR6C74 OR2F1 PTGER4 ACKR3 MRGPRX1 GPR75 AGTR1 MRGPRX3 TACR1 HRH3 | 1.28e-07 | 685 | 124 | 19 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2F2 DRD5 MAS1L HTR4 OR1B1 OR5B2 MLNR MAS1 FPR3 OR6C74 OR2F1 PTGER4 ACKR3 MRGPRX1 GPR75 AGTR1 MRGPRX3 TACR1 HRH3 | 1.47e-07 | 691 | 124 | 19 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2F2 DRD5 MAS1L HTR4 OR1B1 OR5B2 MLNR MAS1 FPR3 OR6C74 OR2F1 PTGER4 ACKR3 MRGPRX1 GPR75 AGTR1 MRGPRX3 TACR1 HRH3 | 1.50e-07 | 692 | 124 | 19 | IPR000276 |
| Domain | NMDAR2_C | 2.86e-07 | 3 | 124 | 3 | PF10565 | |
| Domain | NMDAR2_C | 2.86e-07 | 3 | 124 | 3 | IPR018884 | |
| Domain | MRGPCRFAMILY | 5.89e-07 | 11 | 124 | 4 | IPR026234 | |
| Domain | Lig_chan-Glu_bd | 5.27e-06 | 18 | 124 | 4 | PF10613 | |
| Domain | Glu/Gly-bd | 5.27e-06 | 18 | 124 | 4 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 5.27e-06 | 18 | 124 | 4 | SM00918 | |
| Domain | Iontro_rcpt | 5.27e-06 | 18 | 124 | 4 | IPR001320 | |
| Domain | Iono_rcpt_met | 5.27e-06 | 18 | 124 | 4 | IPR001508 | |
| Domain | Lig_chan | 5.27e-06 | 18 | 124 | 4 | PF00060 | |
| Domain | PBPe | 5.27e-06 | 18 | 124 | 4 | SM00079 | |
| Domain | Clathrin_AP_2 | 4.37e-05 | 2 | 124 | 2 | IPR014712 | |
| Domain | - | 4.37e-05 | 2 | 124 | 2 | 1.20.58.150 | |
| Domain | Serpin_dom | 9.25e-05 | 36 | 124 | 4 | IPR023796 | |
| Domain | ANF_lig-bd_rcpt | 1.03e-04 | 37 | 124 | 4 | IPR001828 | |
| Domain | ANF_receptor | 1.03e-04 | 37 | 124 | 4 | PF01094 | |
| Domain | SERPIN | 1.03e-04 | 37 | 124 | 4 | PS00284 | |
| Domain | Serpin | 1.15e-04 | 38 | 124 | 4 | PF00079 | |
| Domain | Peripla_BP_I | 1.27e-04 | 39 | 124 | 4 | IPR028082 | |
| Domain | Serpin_fam | 1.27e-04 | 39 | 124 | 4 | IPR000215 | |
| Domain | ANTH_dom | 2.60e-04 | 4 | 124 | 2 | IPR011417 | |
| Domain | ANTH | 2.60e-04 | 4 | 124 | 2 | PF07651 | |
| Domain | GPS | 1.47e-03 | 34 | 124 | 3 | SM00303 | |
| Domain | ENTH | 1.53e-03 | 9 | 124 | 2 | PS50942 | |
| Domain | ENTH | 1.53e-03 | 9 | 124 | 2 | SM00273 | |
| Domain | GPS | 1.60e-03 | 35 | 124 | 3 | PF01825 | |
| Domain | GPS | 1.74e-03 | 36 | 124 | 3 | PS50221 | |
| Domain | GPS | 1.88e-03 | 37 | 124 | 3 | IPR000203 | |
| Domain | SERPIN | 1.88e-03 | 37 | 124 | 3 | SM00093 | |
| Domain | Leu-rich_rpt_4 | 1.90e-03 | 10 | 124 | 2 | IPR025875 | |
| Domain | ENTH | 1.90e-03 | 10 | 124 | 2 | IPR013809 | |
| Domain | LRR_4 | 1.90e-03 | 10 | 124 | 2 | PF12799 | |
| Domain | ARM-type_fold | 1.93e-03 | 339 | 124 | 8 | IPR016024 | |
| Domain | LRR | 2.25e-03 | 201 | 124 | 6 | PS51450 | |
| Domain | GFP-like | 2.31e-03 | 11 | 124 | 2 | IPR023413 | |
| Domain | - | 2.31e-03 | 11 | 124 | 2 | 2.40.155.10 | |
| Domain | PKD_channel | 2.31e-03 | 11 | 124 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 2.31e-03 | 11 | 124 | 2 | IPR013122 | |
| Domain | ABC_A | 2.76e-03 | 12 | 124 | 2 | IPR026082 | |
| Domain | Carboxylesterase_B_CS | 3.25e-03 | 13 | 124 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 3.78e-03 | 14 | 124 | 2 | PS00941 | |
| Domain | COesterase | 3.78e-03 | 14 | 124 | 2 | PF00135 | |
| Domain | CarbesteraseB | 3.78e-03 | 14 | 124 | 2 | IPR002018 | |
| Domain | ABC_tran | 3.97e-03 | 48 | 124 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.97e-03 | 48 | 124 | 3 | PS50893 | |
| Domain | - | GBP6 GBP7 ABCA13 LRRK2 GBP1 GBP2 ABCC9 YTHDC2 ABCA10 GBP4 GBP5 AQR | 4.04e-03 | 746 | 124 | 12 | 3.40.50.300 |
| Domain | ABC_TRANSPORTER_1 | 4.21e-03 | 49 | 124 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 4.46e-03 | 50 | 124 | 3 | IPR003439 | |
| Domain | LRR_TYP | 6.57e-03 | 177 | 124 | 5 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 6.57e-03 | 177 | 124 | 5 | IPR003591 | |
| Domain | 7TM_GPCR_Srsx | 6.62e-03 | 112 | 124 | 4 | SM01381 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | DRD5 HTR4 MLNR MAS1 FPR3 GRIN2A GRIN2B GRIN2C GRIN2D PTGER4 AGTR1 TACR1 HRH3 GABRA6 | 2.70e-09 | 272 | 93 | 14 | M13380 |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 8.83e-09 | 5 | 93 | 4 | M47667 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | OR2F2 DRD5 MAS1L HTR4 MLNR MAS1 FPR3 OR2F1 PTGER4 ACKR3 GPR75 AGTR1 HRH3 | 1.48e-08 | 260 | 93 | 13 | M39397 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 2.64e-08 | 6 | 93 | 4 | M47668 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 8.98e-08 | 18 | 93 | 5 | M48098 | |
| Pathway | WP_GPCRS_NONODORANT | DRD5 HTR4 MAS1 PTGER4 TAS2R10 CELSR3 ACKR3 AGTR1 TACR1 TAS2R40 HRH3 | 1.36e-06 | 266 | 93 | 11 | MM15843 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 2.29e-06 | 15 | 93 | 4 | M47691 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 2.30e-06 | 33 | 93 | 5 | M39875 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.75e-06 | 5 | 93 | 3 | MM15655 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 5.06e-06 | 18 | 93 | 4 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 6.38e-06 | 19 | 93 | 4 | M47677 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 7.93e-06 | 20 | 93 | 4 | MM1445 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 9.75e-06 | 21 | 93 | 4 | M27736 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 9.75e-06 | 21 | 93 | 4 | M11650 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 9.75e-06 | 21 | 93 | 4 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 9.75e-06 | 21 | 93 | 4 | M27944 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 1.43e-05 | 23 | 93 | 4 | M27949 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.25e-05 | 178 | 93 | 8 | M2890 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.30e-05 | 87 | 93 | 6 | M27617 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 3.01e-05 | 55 | 93 | 5 | M39763 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 3.28e-05 | 56 | 93 | 5 | M27616 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 4.53e-05 | 98 | 93 | 6 | M965 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL | 5.86e-05 | 12 | 93 | 3 | M47953 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 7.84e-05 | 67 | 93 | 5 | MM15327 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | RASGRF1 ABCC9 GRIN2A GRIN2B GRIN2C GRIN2D ADCY3 NLGN3 SLITRK6 KCNH5 GABRA6 | 8.06e-05 | 411 | 93 | 11 | M735 |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 8.90e-05 | 36 | 93 | 4 | M39831 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.97e-04 | 44 | 93 | 4 | M27934 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD5 HTR4 MLNR FPR3 PTGER4 TAS2R10 ACKR3 AGTR1 TACR1 TAS2R40 HRH3 | 2.29e-04 | 463 | 93 | 11 | M507 |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 2.55e-04 | 47 | 93 | 4 | M39531 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 2.92e-04 | 20 | 93 | 3 | M17670 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 2.92e-04 | 20 | 93 | 3 | MM15485 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 3.24e-04 | 330 | 93 | 9 | M18334 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 3.24e-04 | 50 | 93 | 4 | M39822 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 3.62e-04 | 335 | 93 | 9 | MM14503 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 3.88e-04 | 94 | 93 | 5 | M2843 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.91e-04 | 22 | 93 | 3 | MM15104 | |
| Pathway | KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS | 4.06e-04 | 53 | 93 | 4 | M3812 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.09e-04 | 205 | 93 | 7 | M752 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD5 HTR4 FPR3 PTGER4 TAS2R10 ACKR3 AGTR1 TACR1 TAS2R40 HRH3 | 5.30e-04 | 430 | 93 | 10 | MM15160 |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 6.44e-04 | 105 | 93 | 5 | M27752 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 6.98e-04 | 367 | 93 | 9 | M48346 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 8.08e-04 | 28 | 93 | 3 | M837 | |
| Pathway | WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS | 8.85e-04 | 7 | 93 | 2 | M39867 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.17e-03 | 70 | 93 | 4 | M3115 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.43e-03 | 186 | 93 | 6 | MM15994 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.44e-03 | 74 | 93 | 4 | MM15962 | |
| Pathway | KEGG_PRIMARY_IMMUNODEFICIENCY | 1.56e-03 | 35 | 93 | 3 | M4085 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.56e-03 | 35 | 93 | 3 | MM15109 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.59e-03 | 333 | 93 | 8 | MM14963 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.04e-03 | 270 | 93 | 7 | M15514 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD5 HTR4 MLNR FPR3 PTGER4 ADCY3 TAS2R10 ACKR3 AGTR1 TACR1 TAS2R40 HRH3 | 2.17e-03 | 702 | 93 | 12 | M746 |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 2.32e-03 | 140 | 93 | 5 | M42572 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.62e-03 | 144 | 93 | 5 | MM14501 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 2.65e-03 | 42 | 93 | 3 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 2.65e-03 | 42 | 93 | 3 | MM14971 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 2.70e-03 | 145 | 93 | 5 | M27753 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 3.03e-03 | 44 | 93 | 3 | M11911 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD5 HTR4 FPR3 PTGER4 ADCY3 TAS2R10 ACKR3 AGTR1 TACR1 TAS2R40 HRH3 | 3.44e-03 | 646 | 93 | 11 | MM14962 |
| Pathway | WP_GPCRS_ODORANT | 3.80e-03 | 157 | 93 | 5 | MM15872 | |
| Pathway | WP_RETT_SYNDROME | 3.88e-03 | 48 | 93 | 3 | M39759 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 4.61e-03 | 102 | 93 | 4 | MM15498 | |
| Pubmed | In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. | 6.44e-14 | 8 | 129 | 6 | 16689661 | |
| Pubmed | Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. | 1.05e-12 | 11 | 129 | 6 | 18025219 | |
| Pubmed | A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. | 6.04e-11 | 19 | 129 | 6 | 21551061 | |
| Pubmed | Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. | 8.08e-11 | 9 | 129 | 5 | 24739961 | |
| Pubmed | 1.81e-10 | 4 | 129 | 4 | 8699248 | ||
| Pubmed | 1.81e-10 | 4 | 129 | 4 | 9768843 | ||
| Pubmed | Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. | 2.95e-10 | 11 | 129 | 5 | 24715728 | |
| Pubmed | 5.04e-10 | 12 | 129 | 5 | 35906252 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 9147327 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 21945132 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 11488959 | ||
| Pubmed | Differential distributions of the NMDA receptor channel subunit mRNAs in the mouse retina. | 9.01e-10 | 5 | 129 | 4 | 7510577 | |
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 7929904 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 26919761 | ||
| Pubmed | Distinct distributions of five NMDA receptor channel subunit mRNAs in the brainstem. | 9.01e-10 | 5 | 129 | 4 | 7518475 | |
| Pubmed | Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum. | 9.01e-10 | 5 | 129 | 4 | 7518474 | |
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 8015722 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 15003177 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 7723623 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 12082569 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 12396730 | ||
| Pubmed | Unique features of different members of the human guanylate-binding protein family. | 9.01e-10 | 5 | 129 | 4 | 17266443 | |
| Pubmed | Developmental changes in distribution of NMDA receptor channel subunit mRNAs. | 9.01e-10 | 5 | 129 | 4 | 1493227 | |
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 8036251 | ||
| Pubmed | NMDA receptor activation by HIV-Tat protein is clade dependent. | 9.01e-10 | 5 | 129 | 4 | 19020013 | |
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 21151871 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 26875626 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 8756432 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 18233995 | ||
| Pubmed | 2.69e-09 | 6 | 129 | 4 | 23665428 | ||
| Pubmed | 2.69e-09 | 6 | 129 | 4 | 8996814 | ||
| Pubmed | Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine. | 2.69e-09 | 6 | 129 | 4 | 25760043 | |
| Pubmed | Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. | 2.69e-09 | 6 | 129 | 4 | 9458051 | |
| Pubmed | 2.69e-09 | 6 | 129 | 4 | 15317856 | ||
| Pubmed | 6.27e-09 | 7 | 129 | 4 | 12103442 | ||
| Pubmed | 6.27e-09 | 7 | 129 | 4 | 23267846 | ||
| Pubmed | 6.27e-09 | 7 | 129 | 4 | 19036954 | ||
| Pubmed | HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors. | 6.27e-09 | 7 | 129 | 4 | 22940423 | |
| Pubmed | 6.27e-09 | 7 | 129 | 4 | 22833210 | ||
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 8563977 | ||
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 7695237 | ||
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 17360663 | ||
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 8724036 | ||
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 8822372 | ||
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 21106831 | ||
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 10448428 | ||
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 8955056 | ||
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 10555109 | ||
| Pubmed | Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons. | 1.25e-08 | 8 | 129 | 4 | 8804048 | |
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 8845955 | ||
| Pubmed | HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. | 1.25e-08 | 8 | 129 | 4 | 8821747 | |
| Pubmed | 1.26e-08 | 21 | 129 | 5 | 19158679 | ||
| Pubmed | 2.24e-08 | 9 | 129 | 4 | 21670103 | ||
| Pubmed | 2.24e-08 | 9 | 129 | 4 | 17526495 | ||
| Pubmed | 2.24e-08 | 9 | 129 | 4 | 21491143 | ||
| Pubmed | D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity. | 2.24e-08 | 9 | 129 | 4 | 22552781 | |
| Pubmed | 2.24e-08 | 9 | 129 | 4 | 9892651 | ||
| Pubmed | 2.24e-08 | 9 | 129 | 4 | 16554481 | ||
| Pubmed | 3.73e-08 | 10 | 129 | 4 | 19332541 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 9718984 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 11920728 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 15519237 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 18685090 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 9480759 | ||
| Pubmed | Molecular and genetic determinants of the NMDA receptor for superior learning and memory functions. | 4.99e-08 | 3 | 129 | 3 | 25360708 | |
| Pubmed | Climbing-fibre activation of NMDA receptors in Purkinje cells of adult mice. | 4.99e-08 | 3 | 129 | 3 | 17901118 | |
| Pubmed | HIV-1 Tat-mediated apoptosis in human blood-retinal barrier-associated cells. | 5.84e-08 | 11 | 129 | 4 | 24739951 | |
| Pubmed | 5.84e-08 | 11 | 129 | 4 | 8581564 | ||
| Pubmed | 5.84e-08 | 11 | 129 | 4 | 9647694 | ||
| Pubmed | Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. | 5.84e-08 | 11 | 129 | 4 | 16481105 | |
| Pubmed | 8.74e-08 | 12 | 129 | 4 | 8665664 | ||
| Pubmed | 8.74e-08 | 12 | 129 | 4 | 12815021 | ||
| Pubmed | 8.74e-08 | 12 | 129 | 4 | 11937501 | ||
| Pubmed | 1.76e-07 | 14 | 129 | 4 | 15749123 | ||
| Pubmed | 1.76e-07 | 14 | 129 | 4 | 10373510 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 1377365 | ||
| Pubmed | Heteromeric NMDA receptors: molecular and functional distinction of subtypes. | 1.99e-07 | 4 | 129 | 3 | 1350383 | |
| Pubmed | Structural insights into assembly and function of GluN1-2C, GluN1-2A-2C, and GluN1-2D NMDARs. | 1.99e-07 | 4 | 129 | 3 | 36309015 | |
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 8595214 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 23892010 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 12191494 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 8965641 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 38404575 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 8601798 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 2.39e-07 | 15 | 129 | 4 | 14622581 | |
| Pubmed | Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport. | 2.39e-07 | 15 | 129 | 4 | 21948112 | |
| Pubmed | Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein. | 2.39e-07 | 15 | 129 | 4 | 10479680 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 3.07e-07 | 118 | 129 | 7 | 19156168 | |
| Pubmed | 4.14e-07 | 17 | 129 | 4 | 24086760 | ||
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 9004271 | ||
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 10436022 | ||
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 16190898 | ||
| Pubmed | Essential Role of mGBP7 for Survival of Toxoplasma gondii Infection. | 4.96e-07 | 5 | 129 | 3 | 31964735 | |
| Pubmed | Gene structure and chromosomal localization of the mouse NMDA receptor channel subunits. | 5.31e-07 | 18 | 129 | 4 | 9011744 | |
| Pubmed | 5.99e-07 | 81 | 129 | 6 | 22723691 | ||
| Pubmed | Tulp3 Is a Ciliary Trafficking Gene that Regulates Polycystic Kidney Disease. | 9.89e-07 | 6 | 129 | 3 | 30799240 | |
| Pubmed | 1.03e-06 | 21 | 129 | 4 | 22114277 | ||
| Pubmed | HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. | 1.73e-06 | 7 | 129 | 3 | 11606043 | |
| Pubmed | 1.73e-06 | 7 | 129 | 3 | 12775422 | ||
| Pubmed | 1.73e-06 | 7 | 129 | 3 | 20661302 | ||
| Cytoband | 1p22.2 | 1.57e-10 | 28 | 129 | 6 | 1p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 2.66e-06 | 137 | 129 | 6 | chr1p22 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.90e-08 | 7 | 89 | 4 | 1201 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 4.11e-05 | 78 | 89 | 5 | 262 | |
| GeneFamily | Serpin peptidase inhibitors | 7.94e-04 | 37 | 89 | 3 | 739 | |
| GeneFamily | ATP binding cassette subfamily A | 2.10e-03 | 14 | 89 | 2 | 805 | |
| GeneFamily | Parkinson disease associated genes | 2.75e-03 | 16 | 89 | 2 | 672 | |
| Coexpression | HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 5.23e-07 | 14 | 128 | 4 | M41166 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_8_PRECICTIVE_ICB_RESPONSE | 6.38e-07 | 200 | 128 | 9 | MM17082 | |
| Coexpression | SEKI_INFLAMMATORY_RESPONSE_LPS_UP | 4.40e-06 | 87 | 128 | 6 | MM1253 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 6.07e-06 | 198 | 128 | 8 | MM17083 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 | 1.01e-05 | 28 | 128 | 4 | M1957 | |
| Coexpression | MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_BCG_PRIMED_28DY_UP | 1.33e-05 | 10 | 128 | 3 | M41004 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 | 1.35e-05 | 30 | 128 | 4 | MM835 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN | 1.99e-05 | 33 | 128 | 4 | M41194 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 2.61e-05 | 176 | 128 | 7 | MM1048 | |
| Coexpression | GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP | 4.11e-05 | 189 | 128 | 7 | M9722 | |
| Coexpression | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN | 4.96e-05 | 15 | 128 | 3 | M15662 | |
| Coexpression | HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 5.26e-05 | 42 | 128 | 4 | M41024 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN | 5.70e-05 | 199 | 128 | 7 | M7341 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN | 5.88e-05 | 200 | 128 | 7 | M7807 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 6.12e-05 | 138 | 128 | 6 | MM1047 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 8.05e-05 | 145 | 128 | 6 | MM3744 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 9.95e-05 | 94 | 128 | 5 | M18108 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_OVERLAP_UP | 1.21e-04 | 98 | 128 | 5 | MM460 | |
| Coexpression | ZEMEK_IMMUNE_CHECKPOINT_BLOCKADE_OVARIAN_CANCER_RENCA_UP | 1.33e-04 | 100 | 128 | 5 | MM458 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 1.42e-04 | 21 | 128 | 3 | MM651 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.35e-07 | 121 | 116 | 8 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_500 | 1.56e-06 | 103 | 116 | 7 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | SERPINA3 TBX4 HTR4 TMPRSS13 GBP7 RASGRF1 ZBTB4 GBP1 ABCC9 CSMD3 SLC52A3 SLC12A1 TMEM184A PLXDC2 PCDH11X SLITRK6 | 5.58e-06 | 783 | 116 | 16 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | GBP6 GBP7 GBP1 GBP2 PTPRC GBP4 HMCN1 PLXDC2 ACKR3 AGTR1 SLC4A4 | 1.49e-05 | 408 | 116 | 11 | gudmap_kidney_adult_RenalCapsule_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.90e-05 | 208 | 116 | 8 | gudmap_developingLowerUrinaryTract_adult_bladder_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.42e-05 | 105 | 116 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K4 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_200 | 3.73e-05 | 167 | 116 | 7 | gudmap_kidney_adult_Mesangium_Meis_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_500 | SERPINA3 TMPRSS13 RASGRF1 GBP1 ABCC9 CSMD3 SLC52A3 SLC12A1 TMEM184A SLITRK6 | 5.29e-05 | 387 | 116 | 10 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500 |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_500 | 6.05e-05 | 76 | 116 | 5 | gudmap_kidney_adult_CortVasc_Tie2_k2_500 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_100 | 8.45e-05 | 16 | 116 | 3 | gudmap_kidney_adult_CortVasc_Tie2_k4_100 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#1_top-relative-expression-ranked_200 | 1.06e-04 | 45 | 116 | 4 | gudmap_kidney_adult_Mesangium_Meis_k1_200 | |
| CoexpressionAtlas | kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_500 | 1.15e-04 | 87 | 116 | 5 | gudmap_kidney_adult_GlomCapSys_Tie2_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_200 | 1.22e-04 | 88 | 116 | 5 | gudmap_developingKidney_e15.5_200_k2 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500 | 1.24e-04 | 429 | 116 | 10 | gudmap_kidney_adult_Mesangium_Meis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_500 | 1.26e-04 | 47 | 116 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k4 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.64e-04 | 148 | 116 | 6 | gudmap_kidney_adult_RenCorpuscGlomer_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | 2.33e-04 | 378 | 116 | 9 | gudmap_developingLowerUrinaryTract_adult_bladder_500 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_top-relative-expression-ranked_200 | 2.67e-04 | 162 | 116 | 6 | gudmap_kidney_adult_CortVasc_Tie2_200 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#4_top-relative-expression-ranked_100 | 2.93e-04 | 5 | 116 | 2 | gudmap_kidney_adult_Mesangium_Meis_k4_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | GBP6 GBP7 GBP1 GBP2 CCNG1 PTPRC GBP4 HMCN1 GBP5 PLXDC2 ACKR3 AGTR1 SLC4A4 | 3.31e-04 | 778 | 116 | 13 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500 | REV3L STK11IP TMEM184A PLXDC2 ASXL3 ELAPOR1 MROH7 SLITRK6 ITIH6 MUC4 | 3.48e-04 | 488 | 116 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500 |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.01e-09 | 199 | 129 | 9 | 4b6d49b96bfcd6604b082bab620ae03276520885 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-08 | 184 | 129 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-08 | 184 | 129 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-08 | 184 | 129 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 1.23e-07 | 199 | 129 | 8 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-07 | 200 | 129 | 8 | 0f6620a5baace704518d42fa2f3f90751240f7dd | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-07 | 162 | 129 | 7 | adf545cf9357556e2ce7affed01c2f6a24b0581d | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.04e-06 | 182 | 129 | 7 | e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.12e-06 | 184 | 129 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-06 | 186 | 129 | 7 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.25e-06 | 187 | 129 | 7 | fcc32dbc9c5ae6176f154715a3e73aa32d78ad64 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-06 | 189 | 129 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-06 | 194 | 129 | 7 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.59e-06 | 194 | 129 | 7 | 1b4a17d58793e8889484fe592dce8ee1e8fe77a9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.59e-06 | 194 | 129 | 7 | 5022c85ad3b137dae4b9ff11f9c23bb3bf4c0f5a | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 1.65e-06 | 195 | 129 | 7 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-06 | 196 | 129 | 7 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.77e-06 | 197 | 129 | 7 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.89e-06 | 199 | 129 | 7 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.95e-06 | 200 | 129 | 7 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.95e-06 | 200 | 129 | 7 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.95e-06 | 200 | 129 | 7 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.95e-06 | 200 | 129 | 7 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.95e-06 | 200 | 129 | 7 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.95e-06 | 200 | 129 | 7 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.95e-06 | 200 | 129 | 7 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-DCs|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.95e-06 | 200 | 129 | 7 | e0beacb88bbdc353a3e883171613027feafcf1ef | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.63e-06 | 75 | 129 | 5 | 3167beedef7304697e9577270cdeacfc9743cee1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.63e-06 | 75 | 129 | 5 | 70c346f92a9ac7e33fc1b9dee1dca0bf9ae0a38c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.63e-06 | 75 | 129 | 5 | 26d6e54ed0a6c3ff57f6269c460177bc7b8bf979 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 145 | 129 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 5.44e-06 | 152 | 129 | 6 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-06 | 157 | 129 | 6 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.84e-06 | 162 | 129 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 8.41e-06 | 164 | 129 | 6 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 9.32e-06 | 167 | 129 | 6 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-06 | 169 | 129 | 6 | c3d410a5e98000ba872141b62e17ef4ed3d1a8eb | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 171 | 129 | 6 | 6f49537f8d3cf18e65aa999fec32ed347ce2da3e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 171 | 129 | 6 | ab97ae2b127a585f170f028f1c475cdd1b0cdea5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 177 | 129 | 6 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 177 | 129 | 6 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 177 | 129 | 6 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 178 | 129 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.43e-05 | 180 | 129 | 6 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | Control-APC-like-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.57e-05 | 183 | 129 | 6 | 8f9c8e2436f18ea7c265b08e4e149e19cb513a16 | |
| ToppCell | Control-APC-like|Control / group, cell type (main and fine annotations) | 1.57e-05 | 183 | 129 | 6 | c313ac72cc9fa1583456d452393f61f0a4ca33a8 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.62e-05 | 184 | 129 | 6 | 3e9d75af578297950e469f23fb2d28393a2feef8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-05 | 184 | 129 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.65e-05 | 109 | 129 | 5 | 4e4a884b8979f4ff8b232c1581ea78884dda29ed | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 188 | 129 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 188 | 129 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 189 | 129 | 6 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.88e-05 | 189 | 129 | 6 | 78dcda09109a5cfb04ba069f16ec80987b3ad432 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.88e-05 | 189 | 129 | 6 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.94e-05 | 190 | 129 | 6 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.00e-05 | 191 | 129 | 6 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 2.00e-05 | 191 | 129 | 6 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.06e-05 | 192 | 129 | 6 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | NS-critical-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.12e-05 | 193 | 129 | 6 | 0dd83b21e164147abfd511a927615c40a28781a2 | |
| ToppCell | Leuk-UTI|World / Disease, Lineage and Cell Type | 2.12e-05 | 193 | 129 | 6 | 26119a0b5d7684022fd16b8b73a0ef5a7d70f3d1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.18e-05 | 194 | 129 | 6 | ce0486ce43748ffe486f08fdddd1f6acbfcc6b0e | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.18e-05 | 194 | 129 | 6 | e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 2.18e-05 | 194 | 129 | 6 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 195 | 129 | 6 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.24e-05 | 195 | 129 | 6 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 2.31e-05 | 196 | 129 | 6 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-05 | 196 | 129 | 6 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.38e-05 | 197 | 129 | 6 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-05 | 197 | 129 | 6 | e2983ae16c72371fbf0e5c123de9f4d900724e5e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-05 | 197 | 129 | 6 | f807d8cd377ee58c02be7f71b39cd227f6b4f5df | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.44e-05 | 198 | 129 | 6 | b50074297184bcc044d06e20bb1d3733b9bd8df7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 198 | 129 | 6 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.44e-05 | 198 | 129 | 6 | 8517386a2f0d14c7d5fc6283e4e16b94d7c5732a | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-05 | 199 | 129 | 6 | 98c0d57c247d39bc771d81f4387f8dd01222628e | |
| ToppCell | proximal-Epithelial-Mucous-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.51e-05 | 199 | 129 | 6 | baac580484124b7c36717b607adcf2cb446e631d | |
| ToppCell | proximal-Epithelial-Mucous|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.51e-05 | 199 | 129 | 6 | 15ba36fa6ad73d0e959e42f18d7acbc14e310dc9 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-05 | 199 | 129 | 6 | 841338719d042247966867ac608146395eb8c4d9 | |
| ToppCell | proximal-3-Epithelial-Mucous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.51e-05 | 199 | 129 | 6 | 3018378860de084662be0cc46fce421db3bb9ec9 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-05 | 199 | 129 | 6 | b818d46a39c8782188d82dc8931b8eec9d549dd1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-05 | 199 | 129 | 6 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 2.51e-05 | 199 | 129 | 6 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | COVID-19_Severe-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 2.51e-05 | 199 | 129 | 6 | e4d8bf016fd95a440e30014a75587e097e90cfad | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-05 | 200 | 129 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.59e-05 | 200 | 129 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-05 | 200 | 129 | 6 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.59e-05 | 200 | 129 | 6 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-05 | 200 | 129 | 6 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.59e-05 | 200 | 129 | 6 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.59e-05 | 200 | 129 | 6 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-05 | 200 | 129 | 6 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | Endothelial-Endothelial-F|Endothelial / shred on cell class and cell subclass (v4) | 2.84e-05 | 122 | 129 | 5 | 2cb8bb63c69aed4d4504b9d97219b8707666f950 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2-Inhibitory_Neuron.Gad1Gad2.Pou6f2-Pax6_(Zona_incerta_(ZI))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.16e-05 | 62 | 129 | 4 | 02f0398e18bd61fbfa03bce71ae77e106181abee | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2-Inhibitory_Neuron.Gad1Gad2.Pou6f2-Pax6_(Zona_incerta_(ZI))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.16e-05 | 62 | 129 | 4 | 8fdbced7a2baa1bfb5b1e204128234424a872fe6 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.16e-05 | 62 | 129 | 4 | ff68e007b8b2af4c7fb09139aed92e86907a05da | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.78e-05 | 136 | 129 | 5 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.78e-05 | 136 | 129 | 5 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | Endothelial-F|World / shred on cell class and cell subclass (v4) | 5.30e-05 | 139 | 129 | 5 | 32d3c5d35e6c4205711c3500d736fd108443e6b4 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.30e-05 | 139 | 129 | 5 | 34398a6f21a1e670497655a7bb7f3cde9e117560 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.30e-05 | 139 | 129 | 5 | 450c4152c9fe4ec503271bb3cf93739918c59509 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.48e-05 | 140 | 129 | 5 | 276b3fa924176426efb31112ed4d355407f0b218 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.46e-04 | 50 | 58 | 4 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_INTERFERON | |
| Computational | Genes in the cancer module 146. | 2.14e-04 | 102 | 58 | 5 | MODULE_146 | |
| Drug | 5-(alpha-methyl-4-bromobenzylamino)phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione | 4.90e-09 | 5 | 129 | 4 | ctd:C498554 | |
| Drug | 2-Aminoadipic Acid | 4.90e-09 | 5 | 129 | 4 | ctd:D015074 | |
| Drug | (2S*,3R*)-1-(biphenyl-4-carbonyl)piperazine-2,3-dicarboxylic acid | 4.90e-09 | 5 | 129 | 4 | ctd:C491996 | |
| Drug | SDZ EAA 494 | 4.90e-09 | 5 | 129 | 4 | ctd:C065286 | |
| Drug | norbiotin | 7.53e-09 | 72 | 129 | 8 | CID000446903 | |
| Drug | SKF 38393 | 1.30e-08 | 110 | 129 | 9 | CID000001242 | |
| Drug | Meperidine | 1.46e-08 | 6 | 129 | 4 | DB00454 | |
| Drug | 1,5-(diethylamino)piperidine | 1.46e-08 | 6 | 129 | 4 | CID000004025 | |
| Drug | Naphthols | 1.46e-08 | 6 | 129 | 4 | ctd:D009284 | |
| Drug | SCH 23390 | 2.08e-08 | 116 | 129 | 9 | CID000005018 | |
| Drug | DPCPX | 2.24e-08 | 117 | 129 | 9 | CID000001329 | |
| Drug | 3,4,7,8-tetrahydroquinoline | 2.24e-08 | 16 | 129 | 5 | CID000094356 | |
| Drug | NSC-673323 | 2.36e-08 | 32 | 129 | 6 | CID000384101 | |
| Drug | 7-Cl-Thio-Kyna | 3.16e-08 | 17 | 129 | 5 | CID003035668 | |
| Drug | Tenocyclidine | 3.40e-08 | 7 | 129 | 4 | DB01520 | |
| Drug | tetrazol-5-yl)glycine | 3.40e-08 | 7 | 129 | 4 | CID000126383 | |
| Drug | 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid | 3.40e-08 | 7 | 129 | 4 | ctd:C050592 | |
| Drug | homoquinolinate | 3.40e-08 | 7 | 129 | 4 | CID003080554 | |
| Drug | S)-piperazine-2-carboxylic acid | 3.40e-08 | 7 | 129 | 4 | CID001502069 | |
| Drug | MNQX | 4.36e-08 | 18 | 129 | 5 | CID000130818 | |
| Drug | NBQX | 4.48e-08 | 90 | 129 | 8 | CID003272523 | |
| Drug | arcaine | 5.89e-08 | 19 | 129 | 5 | CID000002227 | |
| Drug | L-687,414 | 6.76e-08 | 8 | 129 | 4 | CID000125556 | |
| Drug | 6-chloroquinoxaline-2,3-diol | 6.76e-08 | 8 | 129 | 4 | CID000081143 | |
| Drug | ES-242-1 | 6.76e-08 | 8 | 129 | 4 | CID000131976 | |
| Drug | SDZ 220-581 | 6.76e-08 | 8 | 129 | 4 | CID000128019 | |
| Drug | 3alpha5betaHS | 6.76e-08 | 8 | 129 | 4 | CID000165024 | |
| Drug | neramexane | 6.76e-08 | 8 | 129 | 4 | CID006433106 | |
| Drug | piperazine-2,3-dicarboxylic acid | 6.76e-08 | 8 | 129 | 4 | CID000280973 | |
| Drug | sulpiride | 7.45e-08 | 96 | 129 | 8 | CID000005355 | |
| Drug | Phenanthrenes | 1.21e-07 | 9 | 129 | 4 | ctd:D010616 | |
| Drug | baclofen | DRD5 GRIN2A GRIN2B GRIN2C GRIN2D ADCY3 PKD1 PKD2 TACR1 GABRA6 | 1.41e-07 | 191 | 129 | 10 | CID000002284 |
| Drug | loperamide | 1.50e-07 | 105 | 129 | 8 | CID000003954 | |
| Drug | pentanol | 1.67e-07 | 23 | 129 | 5 | CID000006276 | |
| Drug | conotoxin GV | 1.78e-07 | 3 | 129 | 3 | ctd:C055407 | |
| Drug | EAB 515 | 3.15e-07 | 11 | 129 | 4 | CID000159489 | |
| Drug | 5-phosphonopentanoic acid | 3.15e-07 | 11 | 129 | 4 | CID002773807 | |
| Drug | oxiracetam | 3.15e-07 | 11 | 129 | 4 | CID000004626 | |
| Drug | o-difluorobenzene | 3.15e-07 | 11 | 129 | 4 | CID000009706 | |
| Drug | Piperazines | 3.15e-07 | 11 | 129 | 4 | ctd:D010879 | |
| Drug | AC1NQH9B | 3.23e-07 | 26 | 129 | 5 | CID005221504 | |
| Drug | 8-OH-DPAT | 3.47e-07 | 117 | 129 | 8 | CID000001220 | |
| Drug | 2-chloropropionate | 3.95e-07 | 27 | 129 | 5 | CID000011734 | |
| Drug | CI-1041 | 4.70e-07 | 12 | 129 | 4 | CID000156328 | |
| Drug | tenocyclidine | 4.70e-07 | 12 | 129 | 4 | CID000062751 | |
| Drug | chlormethiazole | 4.78e-07 | 28 | 129 | 5 | CID000010783 | |
| Drug | propanol | 5.43e-07 | 53 | 129 | 6 | CID000001031 | |
| Drug | 1,10-diaminodecane | 6.76e-07 | 13 | 129 | 4 | CID000001317 | |
| Drug | Agmatine | 6.76e-07 | 13 | 129 | 4 | ctd:D000376 | |
| Drug | AC1L63MU | FPR3 GRIN2A GRIN2B GRIN2C GRIN2D PTGER4 ADCY3 TG SLC12A1 AGTR1 LRBA HRH3 | 6.89e-07 | 347 | 129 | 12 | CID000285703 |
| Drug | piperidine | 7.77e-07 | 130 | 129 | 8 | CID000008082 | |
| Drug | AC1L1CLB | 9.35e-07 | 92 | 129 | 7 | CID000001951 | |
| Drug | remacemide | 9.42e-07 | 14 | 129 | 4 | CID000060510 | |
| Drug | pentamidine | 1.13e-06 | 33 | 129 | 5 | CID000004735 | |
| Drug | BMY 14802 | 1.13e-06 | 33 | 129 | 5 | CID000108046 | |
| Drug | 1,3-di-o-tolylguanidine | 1.27e-06 | 61 | 129 | 6 | CID000007333 | |
| Drug | ACEA-1011 | 1.28e-06 | 15 | 129 | 4 | CID000127872 | |
| Drug | thiokynurenic acid | 1.28e-06 | 15 | 129 | 4 | CID003035667 | |
| Drug | LY 171555 | 1.52e-06 | 142 | 129 | 8 | CID000001257 | |
| Drug | AP-7 | 1.53e-06 | 63 | 129 | 6 | CID000003122 | |
| Drug | biotinyl-L-lysine | 1.54e-06 | 99 | 129 | 7 | CID000083814 | |
| Drug | argiopine | 1.70e-06 | 16 | 129 | 4 | CID000122294 | |
| Drug | metaphit | 1.70e-06 | 16 | 129 | 4 | CID000114745 | |
| Drug | LY233536 | 1.70e-06 | 16 | 129 | 4 | CID000126239 | |
| Drug | C6H12NO5P | 1.77e-06 | 36 | 129 | 5 | CID000104962 | |
| Drug | 3-bromo-7-nitroindazole | 1.77e-06 | 36 | 129 | 5 | CID000001649 | |
| Drug | scopolamine | 2.15e-06 | 200 | 129 | 9 | CID000005184 | |
| Drug | PRE-084 | 2.21e-06 | 17 | 129 | 4 | CID000126402 | |
| Drug | ADCI | 2.21e-06 | 17 | 129 | 4 | CID000130099 | |
| Drug | SKF 82958 | 2.66e-06 | 39 | 129 | 5 | CID000001225 | |
| Drug | 7-OH-DPAT | 2.66e-06 | 39 | 129 | 5 | CID000001219 | |
| Drug | 3-hydroxyglutaric acid | 2.83e-06 | 18 | 129 | 4 | CID000181976 | |
| Drug | phaclofen | 2.87e-06 | 70 | 129 | 6 | CID000001641 | |
| Drug | fentanyl | 3.31e-06 | 111 | 129 | 7 | CID000003345 | |
| Drug | 5'-GMP Na2 | GBP7 GBP1 GBP2 GRIN2A GRIN2B GRIN2C GRIN2D PHEX CELSR3 GBP5 AQR | 3.37e-06 | 335 | 129 | 11 | CID000000761 |
| Drug | L000369 | 3.44e-06 | 41 | 129 | 5 | CID003931705 | |
| Drug | AC1NNRU4 | 3.44e-06 | 41 | 129 | 5 | CID005126051 | |
| Drug | C22H28N2O4 | 3.57e-06 | 19 | 129 | 4 | CID000065570 | |
| Drug | morphine hydrochloride | DRD5 GRIN2A GRIN2B GRIN2C GRIN2D ADCY3 ACKR3 AGTR1 TACR1 LRBA HRH3 KCNH5 GABRA6 | 3.61e-06 | 481 | 129 | 13 | CID000004253 |
| Drug | MAMP | 3.70e-06 | 160 | 129 | 8 | CID000001206 | |
| Drug | 2,4,4'-trichlorobiphenyl | RAG1 STAB2 HTR4 TMPRSS13 INTS7 ABCA13 MAS1 FTSJ1 GRIN2A GRIN2B GRIN2C RALGAPA2 CSMD3 URB1 CELSR3 TMTC3 GBP4 ASXL3 GPR75 PCDH11X MROH7 LRBA HRH3 | 4.08e-06 | 1411 | 129 | 23 | ctd:C081766 |
| Drug | IDRA 21 | 4.44e-06 | 20 | 129 | 4 | CID000003688 | |
| Drug | saclofen | 4.91e-06 | 44 | 129 | 5 | CID000122150 | |
| Drug | AC1L1JJR | 4.91e-06 | 44 | 129 | 5 | CID000005072 | |
| Drug | carbetapentane | 5.46e-06 | 21 | 129 | 4 | CID000002562 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | RAG1 STAB2 HTR4 TMPRSS13 INTS7 ABCA13 MAS1 FTSJ1 GRIN2A GRIN2B GRIN2C RALGAPA2 CSMD3 URB1 CELSR3 TMTC3 GBP4 ASXL3 GPR75 PCDH11X MROH7 LRBA HRH3 | 5.78e-06 | 1441 | 129 | 23 | ctd:C009828 |
| Drug | NS 102 | 6.65e-06 | 22 | 129 | 4 | CID005282252 | |
| Drug | CX516 | 6.65e-06 | 22 | 129 | 4 | CID000148184 | |
| Drug | GTP[S] | DRD5 CLTCL1 MLNR FPR3 PTGER4 ADCY3 TG SNAP91 AGTR1 PKD1 PKD2 TACR1 LRBA HRH3 | 6.82e-06 | 591 | 129 | 14 | CID000001764 |
| Drug | flurothyl | 6.85e-06 | 47 | 129 | 5 | CID000009528 | |
| Drug | acetylcholine | DRD5 HTR4 MLNR GRIN2A GRIN2B GRIN2C GRIN2D ADCY3 AGTR1 TACR1 HRH3 | 6.86e-06 | 361 | 129 | 11 | CID000000187 |
| Drug | One-time | 7.61e-06 | 48 | 129 | 5 | CID000040813 | |
| Drug | 2-butenedioate | 7.72e-06 | 234 | 129 | 9 | CID000000723 | |
| Drug | D-G-G | 8.01e-06 | 23 | 129 | 4 | CID000444866 | |
| Drug | YM90K | 8.01e-06 | 23 | 129 | 4 | CID005486547 | |
| Drug | 5,7-dichlorokynurenic acid | 8.43e-06 | 49 | 129 | 5 | CID000001779 | |
| Drug | AC1L1FA8 | 9.33e-06 | 50 | 129 | 5 | CID000003150 | |
| Drug | aniracetam | 9.43e-06 | 130 | 129 | 7 | CID000002196 | |
| Drug | NSC7524 | 9.56e-06 | 182 | 129 | 8 | CID000005657 | |
| Drug | CGP 39653 | 9.57e-06 | 24 | 129 | 4 | CID006437837 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 3.71e-06 | 8 | 121 | 3 | DOID:3891 (biomarker_via_orthology) | |
| Disease | kallistatin measurement | 3.71e-06 | 8 | 121 | 3 | EFO_0008196 | |
| Disease | epilepsy (implicated_via_orthology) | 5.14e-06 | 163 | 121 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.37e-05 | 14 | 121 | 3 | DOID:898 (implicated_via_orthology) | |
| Disease | Depressive disorder | 2.66e-05 | 289 | 121 | 8 | C0011581 | |
| Disease | cathepsin L1 measurement | 3.62e-05 | 16 | 121 | 3 | EFO_0010619 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.94e-05 | 49 | 121 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Autosomal dominant polycystic kidney disease | 4.99e-05 | 3 | 121 | 2 | cv:C0085413 | |
| Disease | Tourette syndrome | 5.35e-05 | 50 | 121 | 4 | EFO_0004895 | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 9.95e-05 | 4 | 121 | 2 | DOID:898 (is_implicated_in) | |
| Disease | gallbladder carcinoma (is_implicated_in) | 1.65e-04 | 5 | 121 | 2 | DOID:4948 (is_implicated_in) | |
| Disease | laryngeal carcinoma (is_marker_for) | 2.47e-04 | 6 | 121 | 2 | DOID:2600 (is_marker_for) | |
| Disease | Polycystic Kidney Diseases | 2.47e-04 | 6 | 121 | 2 | C0022680 | |
| Disease | Polycystic kidney disease, type 2 | 3.46e-04 | 7 | 121 | 2 | C2751306 | |
| Disease | cognitive disorder (biomarker_via_orthology) | 4.59e-04 | 8 | 121 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | helping behavior measurement | 4.59e-04 | 8 | 121 | 2 | EFO_0008538 | |
| Disease | cystitis (implicated_via_orthology) | 4.59e-04 | 8 | 121 | 2 | DOID:1679 (implicated_via_orthology) | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 4.59e-04 | 8 | 121 | 2 | C0887850 | |
| Disease | skin disease, response to cetuximab | 5.89e-04 | 9 | 121 | 2 | EFO_0000701, EFO_0007682 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 5.89e-04 | 9 | 121 | 2 | C0085413 | |
| Disease | Mental Depression | 6.46e-04 | 254 | 121 | 6 | C0011570 | |
| Disease | Mood Disorders | 6.58e-04 | 168 | 121 | 5 | C0525045 | |
| Disease | Alzheimer's disease (is_marker_for) | 6.87e-04 | 257 | 121 | 6 | DOID:10652 (is_marker_for) | |
| Disease | colitis (biomarker_via_orthology) | 6.87e-04 | 42 | 121 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | Bipolar Disorder | 8.05e-04 | 477 | 121 | 8 | C0005586 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 8.95e-04 | 11 | 121 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 8.95e-04 | 11 | 121 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | vascular dementia (is_marker_for) | 8.95e-04 | 11 | 121 | 2 | DOID:8725 (is_marker_for) | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.07e-03 | 12 | 121 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Epilepsy | 1.07e-03 | 109 | 121 | 4 | C0014544 | |
| Disease | Common variable immunodeficiency | 1.26e-03 | 13 | 121 | 2 | cv:C0009447 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 1.26e-03 | 13 | 121 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | Connective Tissue Diseases | 1.26e-03 | 13 | 121 | 2 | C0009782 | |
| Disease | corpus callosum posterior volume measurement | 1.28e-03 | 52 | 121 | 3 | EFO_0010298 | |
| Disease | myocarditis (implicated_via_orthology) | 1.47e-03 | 14 | 121 | 2 | DOID:820 (implicated_via_orthology) | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 1.47e-03 | 14 | 121 | 2 | DOID:627 (is_implicated_in) | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 1.47e-03 | 14 | 121 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | glycerate measurement | 1.69e-03 | 15 | 121 | 2 | EFO_0021029 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.93e-03 | 16 | 121 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | hypertension (implicated_via_orthology) | 1.94e-03 | 128 | 121 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | response to vaccine, cytokine measurement | 2.11e-03 | 131 | 121 | 4 | EFO_0004645, EFO_0004873 | |
| Disease | cutaneous melanoma, hair color | 2.13e-03 | 62 | 121 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | 4-ethylphenylsulfate measurement | 2.44e-03 | 18 | 121 | 2 | EFO_0021148 | |
| Disease | protein Z-dependent protease inhibitor measurement | 2.44e-03 | 18 | 121 | 2 | EFO_0021849 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 2.48e-03 | 137 | 121 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | Parkinson's disease (is_marker_for) | 2.66e-03 | 67 | 121 | 3 | DOID:14330 (is_marker_for) | |
| Disease | Omenn Syndrome | 2.72e-03 | 19 | 121 | 2 | C2700553 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 3.02e-03 | 20 | 121 | 2 | DOID:3328 (is_marker_for) | |
| Disease | Severe Combined Immunodeficiency | 3.02e-03 | 20 | 121 | 2 | C0085110 | |
| Disease | Manic Disorder | 3.14e-03 | 71 | 121 | 3 | C0024713 | |
| Disease | grip strength measurement | 3.27e-03 | 350 | 121 | 6 | EFO_0006941 | |
| Disease | fetal hemoglobin measurement | 3.33e-03 | 21 | 121 | 2 | EFO_0004576 | |
| Disease | HbA1c measurement, response to sulfonylurea | 3.33e-03 | 21 | 121 | 2 | EFO_0004541, EFO_0007922 | |
| Disease | nasopharyngeal neoplasm | 3.52e-03 | 151 | 121 | 4 | EFO_0004252 | |
| Disease | Attention Deficit Disorder | 3.65e-03 | 22 | 121 | 2 | C0041671 | |
| Disease | dilated cardiomyopathy (biomarker_via_orthology) | 3.65e-03 | 22 | 121 | 2 | DOID:12930 (biomarker_via_orthology) | |
| Disease | C-peptide measurement | 3.65e-03 | 22 | 121 | 2 | EFO_0005187 | |
| Disease | Minimal Brain Dysfunction | 3.65e-03 | 22 | 121 | 2 | C1321905 | |
| Disease | Parkinson disease | 3.65e-03 | 22 | 121 | 2 | cv:C0030567 | |
| Disease | Huntington's disease (is_implicated_in) | 3.99e-03 | 23 | 121 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | urate measurement, bone density | 4.06e-03 | 619 | 121 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | Manic | 4.09e-03 | 78 | 121 | 3 | C0338831 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSNFLNDSSYALQAV | 1136 | Q96N23 | |
| NADYVISLAFISFSI | 1621 | Q7Z407 | |
| LVSFSSFIYFASLNV | 141 | Q8WWZ4 | |
| SANVDFAFSLYKQLV | 51 | P01011 | |
| ARQLLAYTVEAANFS | 441 | Q8IWK6 | |
| ASVSFNLYASVFLLT | 106 | P30556 | |
| VFRNSSLFALANVYA | 161 | Q8N7M0 | |
| YLLSAFFSQANTAAL | 3666 | Q86UQ4 | |
| LTDTNNIAYLFLSAA | 1201 | O60706 | |
| FSTANAGLLYDFQLI | 1166 | O60306 | |
| YLASRNTLFNLSNFL | 96 | O60641 | |
| LVTYQLLAFLDFNNT | 526 | Q8TF62 | |
| RLSTSALNNEFFAYA | 301 | Q9C0F0 | |
| AFIFLSQSLEYAKNS | 1196 | Q68CQ1 | |
| QYSFNSQRFAELLST | 911 | P15918 | |
| NSSLNPVIYAFNADF | 351 | P21918 | |
| LLSNILAAYSFVSEN | 16 | Q9H8M9 | |
| DYFSTQFLLNFAILG | 886 | Q9NVH2 | |
| NTVVANASFTYLTAL | 621 | Q9UFC0 | |
| ATTAFQFLQLYYSLL | 151 | P51959 | |
| QATNFIAFAAQYRSS | 4731 | Q99102 | |
| RANISYTLLFFLFLA | 21 | Q8NGR6 | |
| LIYLVSSFLALNQAS | 6 | O75951 | |
| PFASLNFLDYISSNN | 1236 | Q71F56 | |
| LLFSTINSSANPFIY | 266 | P04201 | |
| LFLFSYATAAQNNTV | 181 | Q9C0I1 | |
| TRTFNYNFSALANTV | 666 | Q6UXG2 | |
| TICYLNLALADFSFS | 61 | P25089 | |
| LLKVLDFYTAFANSF | 646 | Q8NCM2 | |
| FFVALATVENYLLAS | 101 | Q96R09 | |
| AGLTLFAVYASNVLF | 136 | P35408 | |
| QINALTSFLDASFVY | 296 | P22079 | |
| FCSLLYAFSQLAVSL | 16 | Q4G148 | |
| LFSEALNAAQIFAIY | 366 | P50851 | |
| VLAYNLNYATAISSF | 1686 | P09848 | |
| SQLFSYAAFSDSNII | 2341 | Q5S007 | |
| IASSATAFYLQLFLL | 56 | A6NFX1 | |
| FALAVLLSSTFVYNS | 116 | P32455 | |
| FALAILLSSTFVYNS | 116 | P32456 | |
| FALAVLLSSSFVYNS | 131 | Q96PP9 | |
| FALALLLSSTFVYNT | 116 | Q96PP8 | |
| FALAVLLCSTFVYNS | 116 | Q6ZN66 | |
| FALAVLLSSSFVYNS | 116 | Q8N8V2 | |
| SALIEFAAVNYFTNL | 316 | Q16445 | |
| SALNSSANPIIYFFV | 261 | Q96LB0 | |
| FFLTNLSLVDVSYAT | 61 | Q13607 | |
| FFLTNLSLVDVSYAT | 61 | O95006 | |
| VFSNQFLLETAAYLD | 411 | Q9BZA7 | |
| ADLDFIQQAISYSSF | 186 | P78380 | |
| LQLFVFNDSTLISYL | 1426 | Q2PPJ7 | |
| LSAIFLALATYQSLY | 181 | Q9H490 | |
| LSSNGSFILYQFELF | 346 | O95800 | |
| IIFNSANRLFQYAST | 46 | Q02080 | |
| SYLISLFLIINSSAN | 296 | P35410 | |
| FLFALLYSSLAQDAS | 11 | Q96RW7 | |
| SYNDCAAQLFFTILL | 91 | A6NCV1 | |
| QLSNNSVSFFLYNLD | 86 | Q9Y6W8 | |
| ASLLFLNVLAFAALY | 716 | Q9NZ94 | |
| FSLSSFQYLILAAAV | 1051 | Q9NQ11 | |
| FYFLLARAISASSDQ | 231 | P25106 | |
| NYFIVSLAFADLLVS | 56 | Q13639 | |
| LITAQIFSYLGLNFA | 146 | O60266 | |
| AQQLSNVYFTILSLF | 11 | Q8WWX0 | |
| SGILINTFSLAFYSF | 146 | Q96JQ5 | |
| FLSVTFFNLSIYLNI | 211 | Q9Y5N1 | |
| ALSSFLNKASAVYQA | 146 | Q5VWZ2 | |
| SDLQANDYFNIISFS | 311 | Q6UXX5 | |
| YFDNILNSFIVSSLQ | 121 | A8MTL9 | |
| LSFATVQQSGLLFYN | 1541 | Q9NYQ7 | |
| FAALTASQEFLNYLR | 756 | B7ZC32 | |
| FNIVALQLFYLSASI | 336 | O43193 | |
| VLASTASIFLAYNAF | 1821 | Q5VU65 | |
| YLLTVLASNAFENLT | 1101 | P98161 | |
| DLACQNFILASFLTY | 951 | Q5HYA8 | |
| LSDVRFFLNQYSASV | 321 | O43427 | |
| SLSIFYFLKIANFSN | 101 | Q9NYW0 | |
| YIFNAIALFLSTSNI | 256 | P59535 | |
| LSANFSYNALTALDS | 166 | Q8N1F8 | |
| AFIYTLVAFVNALTN | 301 | Q9NQ40 | |
| FLSFQDASSLYRNIL | 746 | Q9H5Y7 | |
| IYNASVSLALYALFL | 226 | Q6ZMB5 | |
| SLSYQFILNLFSFLL | 536 | Q53T94 | |
| VTNYFLVNLAFAEAS | 66 | P25103 | |
| DNYNLGSFTFQATLL | 236 | Q6UX71 | |
| NTAIALSFLIYFISA | 286 | Q8IZM9 | |
| ISNFFLASYALINFS | 571 | Q13621 | |
| AFVSKNNSYSLAFLA | 266 | Q8NCN4 | |
| SALNSSANPIIYFFV | 261 | Q96LB2 | |
| LLQNLLFYFESDSSS | 46 | Q13972 | |
| LASSFTALLQAAYES | 886 | O60287 | |
| TQAVVLSAGFSSFYL | 431 | Q6PIS1 | |
| ASQVYSLNTDFAFRL | 41 | Q86WD7 | |
| NFYSAETILTNFQNL | 156 | Q8IW75 | |
| ADSYFSLLQGFINSL | 61 | Q5VW32 | |
| LFLYFTSTLQNFSLC | 101 | Q6ZSU1 | |
| DTNLYFLALTFFVAA | 281 | Q96KA5 | |
| LLYSNVSNFARLAST | 1216 | P53675 | |
| YLASRNTLFNLSNFL | 96 | Q13492 | |
| NVLAASSEYFQSLFT | 46 | Q9ULJ3 | |
| DFANSFSILRYNSTI | 281 | Q9BYE2 | |
| LIANVTFGYTSANFS | 2726 | O60673 | |
| FQLYPNTSQSATLFL | 3181 | Q15772 | |
| FTVTYTLLNNLQDFL | 386 | Q8WVR3 | |
| FLIQASAQDTAYLYA | 386 | Q86VV4 | |
| FLYLCTSTVQFNSLF | 356 | Q9NYB5 | |
| LSANITAFSNYSATL | 216 | A6NK02 | |
| FSDVLNFIYSARLAL | 136 | Q9P1Z0 | |
| TVNAFYSASTNQIRF | 536 | P78562 | |
| NFLTEVLAYSNSSAR | 2326 | Q8WWQ8 | |
| AANALFTSVFLYQSL | 651 | Q5SNT2 | |
| ATFIDFSVYNANINL | 421 | Q13563 | |
| LENYTNLVSLDFNFT | 36 | Q494X3 | |
| YVANSASALFSQDIS | 556 | Q17R98 | |
| LYSQLQVFFSSVLCA | 166 | Q9UET6 | |
| LSSAALDVNLFIRYF | 346 | Q9H6S0 | |
| SDYFSFVLSLASLNA | 2136 | Q9UPU5 | |
| FYDALNIQALSAILF | 461 | Q9Y6R1 | |
| NAANEFLYSQTFSLS | 511 | P57082 | |
| TFSNILSSAFLGYVL | 106 | Q69YG0 | |
| FLAQTNGNYLALFST | 441 | Q64LD2 | |
| DFRSALFNLALLYSQ | 701 | Q6ZXV5 | |
| STSYNSKALIAFLAF | 571 | P08575 | |
| EAASGNFSLFIQSLY | 811 | P01266 | |
| AASFYQRALLANALT | 51 | P57088 | |
| VARSFYTAIAQAFLS | 2291 | O95071 | |
| FFAVIFLASYTANLA | 636 | Q12879 | |
| AFFAVIFLASYTANL | 636 | Q13224 | |
| AVIFLASYTANLAAF | 636 | Q14957 | |
| AVIFLASYTANLAAF | 666 | O15399 |